Koenig J M, Baron S, Luo D, Benson N A, Deisseroth A B
Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Pediatr Res. 1999 Jun;45(6):867-70. doi: 10.1203/00006450-199906000-00015.
L-selectin, a surface adhesion glycoprotein expressed on leukocytes, has a well-established role in mediating inflammation and lymphocyte recirculation. Recent evidence suggests that L-selectin may also influence hematopoiesis. We observed that a greater proportion of CD34+ cells express L-selectin in cord blood compared with adult bone marrow, and we hypothesized that L-selectin expression is associated with enhanced clonogenic properties. To test this, we compared CD34+/L-selectin+ cells with CD34+/L-selectin- cells in hematopoietic clonogenic assays. From CD34+/L-selectin+ cell cultures, we observed a 3-fold increase of d 12-14 colony-forming unit-granulocyte/macrophage and multipotent progenitor cells, and a 5-fold enhancement of primitive d 21 high proliferative potential colony-forming cells compared with the progeny of CD34+/L-selectin- cells. We conclude that CD34+ cord blood cells expressing L-selectin are enriched in their clonogenic activity compared with cell fractions lacking L-selectin expression.
L-选择素是一种在白细胞上表达的表面黏附糖蛋白,在介导炎症和淋巴细胞再循环方面具有公认的作用。最近的证据表明,L-选择素也可能影响造血作用。我们观察到,与成人骨髓相比,脐带血中更大比例的CD34+细胞表达L-选择素,并且我们推测L-选择素的表达与增强的克隆形成特性相关。为了验证这一点,我们在造血克隆形成试验中比较了CD34+/L-选择素+细胞和CD34+/L-选择素-细胞。与CD34+/L-选择素-细胞的子代相比,从CD34+/L-选择素+细胞培养物中,我们观察到第12 - 14天的集落形成单位-粒细胞/巨噬细胞和多能祖细胞增加了3倍,原始的第21天高增殖潜能集落形成细胞增加了5倍。我们得出结论,与缺乏L-选择素表达的细胞组分相比,表达L-选择素的CD34+脐带血细胞其克隆形成活性更高。